#exter dimensional beings

[rjalker]

I think I'll use "exter" for the 4D term for "higher dimension" since it sounds nice and isn't actually a word outside of like. a random car model that no one cares about.

the 4D equivalent of "up" or "height".

and for the 4D equivalent of "down" or "lower"

I'll use "ineter"

since exter sounds like dexter so may as well make the opposite sound sort of like sinister.

feel free to use, and feel free to suggest variations, since we have multiple words referring to up and down.

[samuriadi-unfiltered]

yes there is BOOKS of lore of 3 through 9- and hopefully one day ill get enough (or do it myself) to make a animated series

where they will rarly show up :^)

im not kidding, they are teachers* and will pick up apprentices rarely- but due to LORE they dont usually show up for long unless very specific thing** happens

*teachers/ but like a jeong jeong teaching aang firebending, they so teach but they do so to make you THINK and ABSORBE the info on a fundamental level--- and not just have you memorize it

while on the subject of them being teachers, do not try to (with intention to kill) attack the apprentices, if youve seen fairytail and ever felt a giddy laugh from seeing a enraged of natsu- woo-boy your not going to be laughing when 3-9 appear and stop the fight cause they are always dead serious outside talking directly to their own apprentices

** multi dimensional/ exter-dimension OC's theres been more characters made over the years- but the interactions between char-char boil down to Char-to-Char politics (not our politics, they dont have government due to not joining in groups above single digits/ again- exter demensional meaning not in a dimension)(not 1,2 or 3rd-dimention like area/size- this is like starwars is its own dimension and batman is on his own dimension)

What were your main inspirations for each of your robots?

(i dont know how long ago this was sent i never check my inbox here)

but i assume by robots draco mwan smy OC's 3 through 9 (thats 3,4,5,6,7,8,9 for those who need it)

the numbers are placeholders while i work on the names and no their not 1 through 7 that be boring

anyway as for the design of them, "3" was the first originally just a visor design and slowly sketched a head- then i made a minecraft skin based off that

(image ref of "3" ill get to when i made this art later)

and then one day when i was 7 to 9 the rest of them just appeared in my head out of nowhere and for the rest of the day i was frantically scetching every detail of ALL SIX of the new ones befor doing more details on "3"

later on around 2009-12 ish i got into digital art and made my own profile pic using "3"

UNFORTUNATELY turns out my compaq 5017 monitor was slightly hugg shifted and what i thought was a silvery-blue arrow turned out to be slightly purple, (rest of the colors where close enough just darkened from what i planned)

each of their symbols have a different color from eachother, starting in the middle is "3" then going from very top (yellow) and clockwise it goes 4 through 9 (orange)

each symbole represents a characteristic or mood of them- and also using a signature move, the lines/curves of each mark are drawn

"9" uses his 2 claws on each hand to do a sideways punch while also doing a upper cut, leaving a # pattern

then turning each arm 45' and doing a lower knuckle bash, (rest of the straight lines)

brings the arms back and does a major fireblast/roar from his mouth, (outer circle)

then putting both claws interlocking together while connecting his hands which transforme into a beast/dragon head, the claws become a square barrel/cannon,

extends the barrel out and "fires" (its not a bullet or laser but does look like a laser not explaining that lore here) leaving the inner circle of the design

(if you get hit by the laser you will not have a circle burn shape you will be just have a hole like any other projectile)

(art of "9" by @wintercataru )

the art style i have are just layered armor based, ive always loved metal even as a kid and read books about other culters metalurgy- and layered armor just stuck the most with me i guess

[risalei-nur]

The Words - The Twenty-seventh  Word - Part 16

Second aspect: No saint can reach the rank of the Companions in nearness to God Almighty, Who is nearer to us than everything while we are infinitely far from Him. One can acquire nearness to Him in two ways. The first way is through God’s favor to make one near to Him and to make one realize His nearness. Through companionship with and succession to the Prophet, the Companions were endowed with this sort of nearness. The second way is through continuous promotion to higher ranks until honored with nearness to God. Most saints follow this way and make a long spiritual journey in their inner world and through the outer world.

The first way is a gift of God and thus does not depend upon one’s efforts. Such nearness is realized through the Merciful One’s attraction and being beloved by Him. This way is short but extremely elevated and sound, perfectly pure and free of obscurity. The other is long, depends on one’s endeavors, and has obscurities. Even if the one following it is endowed with miracle-like wonders, this way is inferior to the former in acquiring nearness to God Almighty. Consider this example: One can experience yesterday once more in two ways. Without following the course of time, one rises by a sacred spiritual power to a position from which all time is seen as a single point. Or, following the course of time, one lives a whole year and reaches the same day next year. Despite this, one cannot preserve yesterday or pre- vent it from passing.

Similarly, one can pass from the external observation of religious com- mandments to the realization of their truth in two ways. Without entering the intermediate world of religious orders, one submits to the truth’s attraction and finds it directly in its external aspect. [In other words, one sees the exter- nal and the internal combined into a single unity.] Or, one is initiated into a spiritual way and continually promoted to higher ranks. But however success- ful they are in self-annihilation and killing their carnal, evil-commanding souls, saints cannot reach the Companions, who were purified, had refined souls, and were honored with all varieties of worship and sorts of praise and thanksgiving with the selfhood’s multiple inborn faculties. The worship of the saints who completely annihilate their selfhood becomes simple and one dimensional.

[medicinethought-blog]

PE

PE

PE is a blockage of an artery in the lungs by a substance that has traveled through the bloodstream (embolism). PE usually results from a blood clot in the leg that travels to the lung.The risk of blood clots is increased by cancer, prolonged bed rest, smoking, stroke, certain genetic conditions, pregnancy, obesity, and after some types of surgery. And can sometimes be due to the embolization of air, fat, or amniotic fluid.

Symptoms

Syspnea (shortness of breath)

Tachypnea (rapid breathing),

Chest pain

Cough

Hemoptysis (coughing up blood).

Cyanosis (blue discoloration, usually of the lips and fingers),

Collapse,

Circulatory instability because of decreased blood flow through the lungs and into the heart

Sudden death

A pleural friction rub

A pleural effusion

Strain on the right ventricle

A fever

Risk factors

Alterations in blood flow due to injury, pregnancy,obesity cancer

Factors in the vessel wall due to surgery, endothelial injury

Factors affecting the properties of the blood due to estrogen-containing hormonal contraception

Cancer

Diagnosis

CT pulmonary angiography (CTPA) is a pulmonary angiogram obtained using CT with radiocontrast. its non-invasive, its larger accessibility, and you can identify other lung disorders from the differential diagnosis in case there is no pulmonary embolism. Assessing the accuracy of CT pulmonary angiography is lowered by the rapid changes in the number of rows of detectors available in multidetector CT (MDCT). CTPA is not inferior to VQ scanning, and identifies more.

A VQ shows that some areas of the lung are being ventilated but not supplied with blood, this type of examination is as accurate as CT, but is less used. It is particularly useful in people who have an allergy to iodinated contrast, impaired renal function, or are pregnant. The test can be performed with two-dimensional imaging, or single photon emission tomography (SPECT) which enables three-dimensional imaging. Hybrid devices combining SPECT and CT (SPECT/CT) further enables identification of abnormalities.

Low chance of PE, a normal D-dimer level (blood test) is enough to portray presence of PE, D-dimer is highly sensitive (positive implies patient doesn’t have PE and visa versa). Full blood count is done, clotting status (PT, aPTT, TT), and some screening tests (erythrocyte sedimentation rate, renal function, liver enzymes, electrolytes).

Treatment

Anticoagulant Therapy

Anticoagulant therapy is the mainstay of treatment. Heparin or fondaparinux are given, while warfarin, acenocoumarol, or phenprocoumon therapy also starts within hospital. Low molecular weight heparin may reduce bleeding among people with pulmonary embolism. Warfarin therapy often requires an often adjustment and monitoring to dosage for up to 6 months. In cancer patients LMWH (low molecular weight heparin) is favored over warfarin and it is continued for six months and pregnant women are often placed on LMWH until at least six weeks after birth to avoid the teratogenic effects of warfarin. (Distort fetus)

Thrombolysis

PE causing hemodynamic instability (low blood pressure) is an indication for thrombolysis (the destruction of the clot with medication). Catheter-directed thrombolysis (CDT) is a new technique found to be relatively safe and effective for massive PEs. This involves accessing the venous system by placing a catheter into a vein in the groin and guiding it through the veins by using fluoroscopic imaging until it is located next to the PE in the plunomary circulation. Medication that breaks up blood clots is released through the catheter.

Inferior vena cava filter

An inferior vena cava filter is constructed if the person has undergone surgery (therefore, anticogulant therapy is contradicted), or a person has a pulmonary embolus after being anticoagulated. It may be implanted to prevent new or existing Deep vein thrombosis from entering the pulmonary artery and combining with an existing blockage. Inferior vena cava filters should be removed when starting anticoagulation.

(An ECG with someone with pulmonary embolism)

References

“What Is Pulmonary Embolism?”. NHLBI. July 1, 2011

“What Are the Signs and Symptoms of Pulmonary Embolism?”. NHLBI. July 1, 2011.

Tintinalli, Judith E. (2010). Emergency Medicine: A Comprehensive Study Guide (Emergency Medicine (Tintinalli)) (7 ed.). New York: McGraw-Hill Companies. p. 432.

Goldhaber SZ (2005). “Pulmonary thromboembolism”. In Kasper DL, Braunwald E, Fauci AS, et al. Harrison’s Principles of Internal Medicine (16th ed.). New York, NY: McGraw-Hill. pp. 1561–65.

Lewis, S; Dirksen, S; Heitkemper, M; Bucher, L (2014). Medical-surgical nursing: Assessment and management of clinical problems (9 ed.). St. Louis, MO: Elsevier Mosby. p. 552

Stein PD, Sostman HD, Hull RD, Goodman LR, Leeper KV, Gottschalk A, Tapson VF, Woodard PK (March 2009). “Diagnosis of Pulmonary Embolism in the Coronary Care Unit”. Am. J. Cardiol. 103 (6): 881–6.

Pregerson DB, Quick Essentials: Emergency Medicine, 4th edition. EMresource.org

Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK (Apr 26, 2011). American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation,American Heart Association Council on Peripheral Vascular Disease,American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. “Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.”. Circulation. 123 (16): 1788–830.

Ferri, F (2012). Ferri’s Clinical Advisor. St. Louis: Mosby’s.

Carrier M, Righini M, Djurabi RK, Huisman MV, Perrier A, Wells PS, Rodger M, Wuillemin WA, Le Gal G (May 2009). “VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies”. Thromb. Haemost. 101 (5): 886–92.

Schrecengost JE, LeGallo RD, Boyd JC, Moons KG, Gonias SL, Rose CE, Bruns DE (September 2003). “Comparison of diagnostic accuracies in outpatients and hospitalized patients of D-dimer testing for the evaluation of suspected pulmonary embolism”. Clin. Chem. 49 (9):

Schouten HJ, Geersing GJ, Koek HL, Zuithoff NP, Janssen KJ, Douma RA, van Delden JJ, Moons KG, Reitsma JB (May 3, 2013). “Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis.”. BMJ (Clinical research ed.).

van Es, N; van der Hulle, T; van Es, J; den Exter, PL; Douma, RA; Goekoop, RJ; Mos, IC; Galipienzo, J; Kamphuisen, PW; Huisman, MV; Klok, FA; Büller, HR; Bossuyt, PM (16 August 2016). “Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysis.”. Annals of Internal Medicine. 165 (4): 253–61.

Söhne, Maaike; Ten Wolde, Marije; Büller, Harry R. (1 November 2004). “Biomarkers in pulmonary embolism”. Current Opinion in Cardiology. 19 (6): 558–562.

Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP (2008). “Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)”. European Heart Journal. 29 (18): 2276–2315.

Stein PD, Freeman LM, Sostman HD, Goodman LR, Woodard PK, Naidich DP, Gottschalk A, Bailey DL, Matta F, Yaekoub AY, Hales CA, Hull RD, Leeper KV, Tapson VF, Weg JG (2009). “SPECT in acute pulmonary embolism”. J Nucl Med (Review). 50 (12): 1999–2007.

Konstantinides, S; Torbicki, A; Agnelli, G; Danchin, N; Fitzmaurice, D; Galiè, N; Gibbs, JSR; Huisman, M; Humbert, M; Kucher, N (14 November 2014). “2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism”. European Heart Journal. 35 (43): 3033–3069.

Da Costa Rodrigues, J; Alzuphar, S; Combescure, C; Le Gal, G; Perrier, A (5 July 2016). “Diagnostic characteristics of lower limb venous compression ultrasonography in suspected pulmonary embolism: a meta-analysis.”. Journal of thrombosis and haemostasis : JTH. 14: 1765–72.

Schaefer-Prokop C, Prokop M (2005). “MDCT for the diagnosis of acute pulmonary embolism”. European radiology.

Van Strijen MJ, De Monye W, Kieft GJ, Pattynama PM, Prins MH, Huisman MV (2005). “Accuracy of single-detector spiral CT in the diagnosis of pulmonary embolism: a prospective multicenter cohort study of consecutive patients with abnormal perfusion scintigraphy”. Journal of thrombosis and haemostasis : JTH. 3 (1): 17–25.

Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV, Popovich J, Quinn DA, Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK (2006). “Multidetector computed tomography for acute pulmonary embolism”. N. Engl. J. Med. 354 (22): 2317–27.Anderson DR, Kahn SR, Rodger MA, Kovacs MJ, Morris T, Hirsch A, Lang E, Stiell I, Kovacs G, Dreyer J, Dennie C, Cartier Y, Barnes D, Burton E, Pleasance S, Skedgel C, O'Rouke K, Wells PS (2007). “Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism”. JAMA. 298 (23):

Scarsbrook AF, Gleeson FV (2007). “Investigating suspected pulmonary embolism in pregnancy”. BMJ. 334 (7590): 418–9.

Leung AN, Bull TM, Jaeschke R, Lockwood CJ, Boiselle PM, Hurwitz LM, James AH, McCullough LB, Menda Y, Paidas MJ, Royal HD, Tapson VF, Winer-Muram HT, Chervenak FA, Cody DD, McNitt-Gray MF, Stave CD, Tuttle BD (2011-11-15). “An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy”. American Journal of Respiratory and Critical Care Medicine. 184 (10): 1200–8.

National Institute for Health and Clinical Excellence. Clinical guideline 144: Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. London, 2012. Benson MD (October 2012). “Pulmonary embolism in pregnancy. Consensus and controversies.”. Minerva ginecologica. 64 (5): 387–98.

Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A (2006). “D-dimer testing to determine the duration of anticoagulation therapy”. N. Engl. J. Med. 355 (17): 1780–9.

Yoo, HH; Queluz, TH; El Dib, R (Apr 28, 2014). “Anticoagulant treatment for subsegmental pulmonary embolism.”. The Cochrane database of systematic reviews.  Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ (June 2008). “Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)”. Chest. 133 (6): 71–109

Lavonas, EJ; Drennan, IR; Gabrielli, A; Heffner, AC; Hoyte, CO; Orkin, AM; Sawyer, KN; Donnino, MW (3 November 2015). “Part 10: Special Circumstances of Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.”. Circulation.

“References in Catheter-directed Therapy for the Treatment of Massive Pulmonary Embolism: Systematic Review and Meta-analysis of Modern Techniques - Journal of Vascular and Interventional Radiology”. www.jvir.org.

Hao, Q; Dong, BR; Yue, J; Wu, T; Liu, GJ (30 September 2015). “Thrombolytic therapy for pulmonary embolism.”. The Cochrane database of systematic reviews (9)

Nakamura, S; Takano, H; Kubota, Y; Asai, K; Shimizu, W (Jul 2014). “Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis.”. Journal of thrombosis and haemostasis : JTH. 12 (7): 1086–95.

Chatterjee, Saurav; Chakraborty, Anasua; Weinberg, Ido; Kadakia, Mitul; Wilensky, Robert L.; Sardar, Partha; Kumbhani, Dharam J.; Mukherjee, Debabrata; Jaff, Michael R.; Giri, Jay (18 June 2014). “Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage”. JAMA. 311 (23): 2414.

Young, Tim; Tang, Hangwi; Hughes, Rodney (2010-02-17). Vena caval filters for the prevention of pulmonary embolism. John Wiley & Sons, Ltd.

[rjalker]

~the lovecraftian horrors view us the same way we see ants! Aaaah!!!! scream!!! it's so scary!!!!!!!!~

you've never spoken to a naturalist before

so here's a concept for people who aren't boring:

~lovecraftian horror~ (exter-dimensional being) who views us the way we view ants. And stops a catastrophic flood by putting a stick down to divert it from the "nest". Who offers food from above when there's none to be found. Who sits quietly out of the way observing but not bothering.

Maybe go fucking watch some ants. Go talk to ant nerds. maybe stop viewing ants as disposable things you can kill and torture for fun. that's a personal fucking problem you have that you should fix if that's how you view ants.